Overview
Melissa B. Daluvoy, MD, is a fellowship trained, board-certified ophthalmologist, with expertise in the medical and surgical treatment of cornea and anterior segment diseases. She performs routine and complex cataract surgeries and offers astigmatism and presbyopia correcting intraocular lenses.
She specializes in advanced corneal transplantation procedures including PK, DSEK, DALK and keratoprosthesis. She performs other anterior segment procedures (Intacs, ptyergia excisions, etc.) as well as refractive surgeries including custom bladeless Intralase LASIK, PRK, PTK and phakic intraocular lenses (implantable contact lenses). She has a special interest in the management of ocular surface diseases like dry eye and blepharitits; and she offers the new Lipiflow procedure.
Dr. Daluvoy is dedicated to delivering personalized treatment while providing high level patient care. She has several publications and is a member of the American Academy of Ophthalmology and American Society of Cataract and Refractive Surgery.
Dr. Daluvoy lives in Durham with her family and is an avid runner.
She specializes in advanced corneal transplantation procedures including PK, DSEK, DALK and keratoprosthesis. She performs other anterior segment procedures (Intacs, ptyergia excisions, etc.) as well as refractive surgeries including custom bladeless Intralase LASIK, PRK, PTK and phakic intraocular lenses (implantable contact lenses). She has a special interest in the management of ocular surface diseases like dry eye and blepharitits; and she offers the new Lipiflow procedure.
Dr. Daluvoy is dedicated to delivering personalized treatment while providing high level patient care. She has several publications and is a member of the American Academy of Ophthalmology and American Society of Cataract and Refractive Surgery.
Dr. Daluvoy lives in Durham with her family and is an avid runner.
Current Duke Appointments & Affiliations
Associate Professor of Ophthalmology
·
2021 - Present
Ophthalmology, Corneal Diseases,
Ophthalmology
Chief, Corneal Ophthalmology
·
2025 - Present
Ophthalmology, Corneal Diseases,
Ophthalmology
Recent Scholarly Works
Mucopolysaccharidosis type I with retinal degeneration and absence of corneal involvement in the eighth decade of life.
Journal article Ophthalmic Genet · June 5, 2026 INTRODUCTION: Mucopolysaccharidosis type I (MPS I) is an autosomal recessive lysosomal storage disorder caused by mutations in IDUA, resulting in ⍺-L-iduronidase loss of function and glycosaminoglycan accumulation. Corneal clouding is the most consistent o ... Full text Link to item CiteVisually significant corneal deposits associated with rifabutin therapy for Bartonella henselae.
Journal article Am J Ophthalmol Case Rep · June 2026 PURPOSE: To report the clinical and histopathological features of a case of visually significant corneal deposits due to rifabutin therapy used to treat Bartonella henselae. OBSERVATIONS: A 73-year-old male with a history of recurrent bartonellosis on rifa ... Full text Link to item CiteBayesian Analysis of Valacyclovir Treatment Effect in the Zoster Eye Disease Study.
Journal article Ophthalmology · January 2026 Full text Link to item CiteRecent Grants
CAM-101
Clinical TrialPrincipal Investigator · Awarded by Cambium · 2018 - 2020Multicenter Evaluation of Time, Operational and Economic Efficiencies of AcrySof IQ Aspheric IOL with the UltraSertTM Preloaded IOL Delivery System
ResearchPrincipal Investigator · Awarded by QuintilesIMS Inc · 2016 - 2016View All Grants
Education
Thomas Jefferson University, Sidney Kimmel Medical College ·
2005
M.D.
The University of Scranton ·
2001
M.P.T.
The University of Scranton ·
2000
B.S.